Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach. [electronic resource]
- Journal of thrombosis and haemostasis : JTH Aug 2013
- 1443-8 p. digital
Publication Type: Journal Article; Review
1538-7836
10.1111/jth.12324 doi
Administration, Oral Anticoagulants--therapeutic use Hemorrhage--prevention & control Humans Morpholines--therapeutic use Randomized Controlled Trials as Topic Research Design Risk Rivaroxaban Thiophenes--therapeutic use Venous Thromboembolism--therapy